Also known as آسٹیوپوروسس مینجمنٹ
Endocrinologist
MBBS, FCPS (Medicine), MCPS (Medicine), FCPS (Endocrinology), FRCP (London) , FRCP (Edinburgh) , FACE (USA)
Endocrinologist
MBBS, FCPS (Medicine), MCPS (Medicine), FCPS (Endocrinology), FRCP (London) , FRCP (Edinburgh) , FACE (USA)
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Consultant Physician
MBBS, FCPS
Internal Medicine Specialist
MBBS, MD (Internal Medicine), FACP, DABIM
Cardiologist
MBBS, FCPS (Cardiology), Certified in ACLS (American Heart Association)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.-II (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures